Brand-name drug
Azstarys price, strengths & recalls
Brand of dexmethylphenidate / serdexmethylphenidate (generic)
Pharmacies pay $431.96 for 30 capsules of Azstarys 5.2 mg / 26.1 mg capsule this week, and from $431.96 to $432.44 across its 3 priced strengths and forms. Its official label last changed on May 13, 2026.
Brand- Fair cash price
- $507.25
- Strengths
- 3
- Makers
- 1
- Updated
- Nov 11
Azstarys price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5.2 mg / 26.1 mg capsule Brand | $14.40 | $431.96 / 30 capsules |
| 7.8 mg / 39.2 mg capsule Brand | $14.41 | $432.44 / 30 capsules |
| 10.4 mg / 52.3 mg capsule Brand | $14.41 | $432.41 / 30 capsules |
The lowest cost per capsule is 5.2 mg / 26.1 mg capsule at $14.40. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Azstarys vs generic dexmethylphenidate / serdexmethylphenidate
There is no generic version of Azstarys on the market yet. Its last listed patent or exclusivity runs to December 9, 2037 - generics often follow, though court cases and settlements can move the date either way.
GenericDexmethylphenidate / serdexmethylphenidate pricesSupply status: shortages & recalls
What people paid for Azstarys
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use AZSTARYS safely and effectively. See full prescribing information for AZSTARYS. AZSTARYS® (serdexmethylphenidate and dexmethylphenidate) capsules, for oral use, CII Initial U.S. Approval: 2021
WARNING: ABUSE, MISUSE, AND ADDICTION
AZSTARYS has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including AZSTARYS, can result in overdose and death [see Overdosage (
10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.
Before prescribing AZSTARYS, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout AZSTARYS treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (
5.1) and Drug Abuse and Dependence (
9.2)].
WARNING: ABUSE, MISUSE, AND ADDICTION
See full prescribing information for complete boxed warning.
AZSTARYS has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including AZSTARYS, can result in overdose and death (
5.1,
9.2,
10):
Before prescribing AZSTARYS, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.
Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Indications and Usage (
1) 09/2025
Warnings and Precautions (
5.7) 09/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA212994 · Commave Sub
- First approved
- March 2, 2021 (5 years ago)
- Latest approved change
- September 23, 2025
- Approved label
- PDF, Sep 25, 2025
- Generic makers
- None on the market
- Last patent listed
- December 9, 2037
- Exclusivity ends
- May 7, 2026 (ended)
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Azstarys questions
How much does azstarys cost without insurance?
Pharmacies pay about $431.96 for 30 capsules of azstarys 5.2 mg / 26.1 mg capsule ($14.40 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $507.25. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Azstarys?
Yes: dexmethylphenidate / serdexmethylphenidate. Compare dexmethylphenidate / serdexmethylphenidate prices.
Is azstarys in shortage?
No shortage is reported for azstarys right now. We check the national shortage list every day.
Has azstarys been recalled?
No recalls are on record for azstarys.
When did the azstarys label last change?
The official label was last updated on May 13, 2026 (version 9). See what changed.
Talk about azstarys
No comments yet. Questions, tips, what worked for you - start the conversation.